The Justice Department’s November challenge of UnitedHealth’s proposed acquisition of home health and hospice services provider Amedisys says the deal would stifle competition for home care in 23 states and Washington, D.C., and lead to higher prices.
But what’s “conspicuously missing” from the complaint is detailed information about relevant geographic areas where competition will be substantially lessened—a necessary component of antitrust merger actions—the companies argued Wednesday in the ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.